Treatments: track first, then decide.

1. Why should you only change one hair loss treatment at a time?

You should only change one treatment at a time because stacking multiple changes makes it impossible to know which variable is driving improvement or causing side effects. The fastest way to fail is to stack changes. If you start Finasteride, Minoxidil, and a new Ketoconazole shampoo in the same week, you will never know which one is driving regrowth or which one is causing a scalp flare-up. Most treatment failures are not biological - they are methodological. The treatment may be working, but you will never know because you cannot attribute the result.

• The Single Variable Rule: Only introduce one new biological variable every 12 to 16 weeks. This means if you are starting Finasteride, do not change your shampoo, add a supplement, or start microneedling at the same time. Each of these is a separate variable that needs its own evaluation window.
• The Adherence Floor: Aim for 90% adherence. If you miss more than 2 doses per week, your trend data becomes technically invalid. You cannot evaluate a treatment you are not consistently taking. Below 80% adherence, the data is noise.
• Dosage Consistency: Changing dosage (e.g., from 1mg to 0.5mg Finasteride) is a variable change. Log it as a new phase in the app. A dose reduction may be clinically appropriate, but treat it as the start of a new evaluation window.
• Timing Consistency: Taking Minoxidil at 7am one day and 11pm the next creates uneven exposure levels. Pick a consistent time slot and stick to it. This is especially important for topical treatments where contact time and absorption matter.

Common Isolation Mistakes

The most frequent protocol violations we see are: starting a biotin supplement at the same time as Minoxidil (biotin has no clinical evidence for MPB, so it adds noise without signal), switching from brand-name to generic mid-evaluation (bioequivalent does not mean identical), and changing hair products (new shampoo, new styling products) during an active evaluation window. If it touches your scalp, it is a variable.

2. What is the difference between finasteride and minoxidil?

Finasteride is a DHT-blocker that stops further hair loss by reducing the hormone causing miniaturization, while minoxidil is a growth agonist that stimulates regrowth by extending the hair growth phase. Understanding what each treatment actually does prevents the frustration of “I'm still losing hair.” These two treatment categories have fundamentally different mechanisms, goals, and success metrics. Using the wrong metric to judge the wrong treatment is the most common source of premature quitting.

DHT-Blockers (The Shield)

Drugs like Finasteride and Dutasteride focus on stopping the miniaturization engine by inhibiting the 5-alpha reductase enzyme. Finasteride blocks Type II 5AR and reduces scalp DHT by approximately 60-70%. Dutasteride blocks both Type I and Type II, reducing scalp DHT by approximately 90%.

Goal: Maintenance. If your 12-month scans show zero change from baseline, the drug is technically a 100% success. Many men quit Finasteride because they “didn't see regrowth,” when in reality, stopping the progression of hair loss is precisely what the drug was designed to do. Regrowth is a bonus, not the baseline expectation.

What to track: Compare zone-specific density at 6-month and 12-month intervals. Stability equals success. Any measured improvement is above-expectation performance. Focus on the hairline and vertex zones where DHT sensitivity is highest.

Growth Agonists (The Engine)

Drugs like Minoxidil focus on vasodilation and extending the anagen (growth) phase. They do not stop the DHT engine - they push the growth pedal harder. Minoxidil works by opening potassium channels in the follicle, which increases blood flow and nutrient delivery.

Goal: Regrowth and thickening. These are best evaluated by diameter expansion in crown scans and increased follicular density in vertex photos. The mechanism is independent of DHT, which is why Minoxidil and Finasteride can be used together - they address different parts of the problem.

What to track: Look for increased hair caliber (thicker individual hairs), improved scalp coverage in vertex/crown photos, and decreased part-line visibility. Minoxidil tends to show strongest results in the crown and mid-scalp, with more modest effects at the hairline.

3. How long does it take for hair loss treatments to work?

Hair loss treatments take a minimum of 6 months (180 days) to produce reliable, measurable results, and 12 months provides a much more complete picture. Follicles move slowly. A single hair cycle lasts months. Judging a treatment after 4 weeks is like checking your investment portfolio hourly - the short-term noise overwhelms the actual signal. The minimum evaluation window for any hair loss treatment is 180 days (6 months), and 12 months provides a much more reliable data set.

Why Most People Quit Too Early

Studies show that over 50% of Finasteride users discontinue within the first year, with the majority quitting in months 2-4. This is precisely the window where the dread shed is resolving and early positive changes have not yet become visible. The men who persist through month 6 with 90%+ adherence are the ones who see results in the clinical data. Your tracking photos provide the objective evidence to keep going when your subjective perception says “nothing is happening.”

4. How should you track hair loss treatment results for your doctor?

You should track treatment results by maintaining an adherence log, a side-effect journal, zone-specific photo comparisons, and numerical scoring so your doctor receives a trend line instead of a subjective impression. If you talk to a clinician, do not bring “I think it looks better.” Bring a trend line. Dermatologists see hundreds of patients, and the ones who bring structured data get better care because the clinician can make faster, more confident decisions.

• Adherence Log: Keep a daily log of application. Note missed doses with the reason (forgot, traveled, side effect). This lets you and your doctor calculate true adherence percentage and correlate any changes with adherence drops.
• Side-Effect Journal: Note symptoms (libido, mood, scalp itch, headache) immediately when they happen, not months later from memory. Include severity on a 1-5 scale and duration. This creates an objective timeline that helps distinguish real side effects from nocebo responses.
• Zone Scoring: Use the Balding AI 0-10 scale to convert photos into numbers that a doctor can quickly scan. Trend data across 4+ data points is far more useful than a single photo comparison.
• Photo Protocol: Same lighting, same angle, same distance, same time of day. Wet and dry hair photos for each zone. Tag each photo set with the current treatment phase and adherence percentage for that period.

Free · takes 30 seconds

Track your results, not your feelings

AI-scored scans remove the guesswork. See exactly what your treatment is doing.

How tracking works →

Your scans stay private. Delete or export anytime.

5. How should you combine finasteride and minoxidil safely?

You should combine finasteride and minoxidil by introducing them sequentially, starting the DHT-blocker first for 6 months, then adding the growth agonist with a fresh baseline so you can attribute results to each treatment individually. Most hair loss specialists recommend combination therapy - typically a DHT-blocker plus a growth agonist. The key is to not start them at the same time. The correct approach is sequential introduction with isolated evaluation windows.

1. Phase 1 (Months 1-6): Start with the DHT-blocker (Finasteride or Dutasteride). This addresses the root cause. Establish baseline photos before your first dose, then track at 8-week intervals.
2. Phase 2 (Months 7-12): After 6 months on the DHT-blocker, add the growth agonist (Minoxidil). Take new baseline photos on the day you start. This way, you can attribute any further improvement to the Minoxidil specifically.
3. Phase 3 (Optional, Months 13+): Consider adjunct therapies like microneedling (derma rolling/stamping at 1.0-1.5mm depth) or Ketoconazole shampoo. Again, introduce one at a time with at least 12 weeks between additions.

This sequential approach takes longer, but it gives you a clear understanding of what each treatment contributes to your results. If you experience a side effect, you know exactly which treatment to adjust. If you see improvement, you know exactly which treatment is responsible.

6. When should you switch or escalate your hair loss treatment?

You should consider switching or escalating when your tracking data shows objective, patterned worsening across two consecutive 8-week windows (16 weeks total) despite maintaining 90% or higher treatment adherence. If your scans show this pattern, that is the technical signal to discuss an escalation with your doctor. Do not pivot based on feelings, mirror checks, or a single bad photo. The data has to show a consistent trend.

Escalation Path: Baseline → Track 6 Months → Review Trend → Adjust Dosage or Drug → Establish New Baseline → Track 6 More Months.

Common escalation options include:

• Dose adjustment: Finasteride 0.5mg → 1mg, or adding 3x/week dosing if daily is not tolerated.
• Drug switch: Finasteride → Dutasteride (stronger 5AR inhibition, ~90% vs. ~70% DHT reduction).
• Delivery change: Oral Minoxidil (low-dose, 2.5-5mg) if topical is not producing results or causing irritation.
• Adjunct addition: Adding microneedling to a Minoxidil regimen has shown synergistic effects in clinical studies.
• Surgical consultation: If medical therapy has stabilized your loss but you want density restoration, a hair transplant discussion is appropriate after 12+ months of stable results on medication.

7. Are finasteride side effects real or nocebo?

Finasteride side effects are real but are also significantly amplified by the nocebo effect, where awareness of potential symptoms increases the likelihood of reporting them. Side effects are real and deserve attention, but the nocebo effect is equally real. Studies show that men who are informed about potential sexual side effects before starting Finasteride report them at significantly higher rates than men in blinded trials. This does not mean side effects do not exist - it means your perception can amplify or create symptoms.

The best defense against both real side effects and nocebo is objective tracking:

• Log your baseline state before starting treatment. Rate libido, mood, energy, and any relevant metrics on a 1-10 scale for at least 2 weeks before your first dose.
• Continue the same daily ratings after starting treatment. This gives you an actual before/after comparison rather than a vague sense that “something changed.”
• If a metric drops by 3+ points for 2+ consecutive weeks, that is a signal worth discussing with your prescribing doctor.
• If you and your doctor decide to stop a treatment, continue tracking the same metrics. Most Finasteride side effects resolve within 2-4 weeks of discontinuation.

8. How do you make evidence-based hair loss treatment decisions?

You make evidence-based treatment decisions by establishing a baseline before starting anything, committing to a 180-day evaluation timeline, isolating variables, and tracking adherence so your data is valid. The modern hair loss landscape is filled with expensive, unproven gadgets and predatory marketing. The only way to navigate it is with technical discipline. Every treatment claim should be met with the same question: “What does my data show?”

Establish your baseline before you start anything. Commit to the timeline - 180 days minimum. Isolate your variables so you know what is actually working. Track your adherence so the data is valid. And when you sit down with a clinician, bring numbers, not narratives. That is how you make evidence-aware decisions about your hair.